(From Fierce Pharma) - Totally worth checking out the source.
1. Miles White - Abbott - $33.4M
2. Fred Hassan - Schering-Plough - $30.1M
3. Bill Weldon - Johnson & Johnson - $25.1M
4. Bob Essner - Wyeth - $24.1M
5. Robert Parkinson - Baxter - $17.6M
6. Daniel Vasella - Novartis - $15.5M
7. Richard Clark - Merck - $14.5M
8. Frank [...]
A while back, I wrote a post detailing my confused wonder at a proposed spin-off from Enzon of a biotech with all of the discovery engine. It turns out, I wasn’t the only one that was confused. In a letter, key Enzon shareholders wrote a letter demanding Enzon, “explore all setrategic alternatives for [...]
Recent Comments